Trials / Unknown
UnknownNCT05602090
Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials
Effect of Growth Hormone Adjuvant Therapy on ICSI Trials For Poor Ovarian Reserve Patients
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Effect of Growth Hormone Adjuvant Therapy on ICSI Trials For Poor ovarian Reserve Patients
Detailed description
To study the effect of growth hormone as adjuvant treatment on the outcomes of ICSI trials in poor ovarian reserve patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 4 IU of recombinant GH (Somatotropin ) | 4 IU of recombinant GH |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-09-04
- Completion
- 2023-10-30
- First posted
- 2022-11-01
- Last updated
- 2023-04-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05602090. Inclusion in this directory is not an endorsement.